

Banks are lining up approximately $2.35 billion in debt to support the proposed leveraged buyout of Patterson Companies Inc., a supplier of everything from dental equipment to drugs for pets and livestock.
Patterson Companies overall top-line figure for the third quarter of fiscal 2025 reflects weak segmental performance.
BALA CYNWYD, Pa., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no cost or financial obligation to you.
Patterson Companies overall topline in the second quarter of fiscal 2025 benefits from strength in its Animal Health segment.
Investors remain optimistic about Patterson Companies on the back of its broad product line.
Investors remain optimistic about Patterson Companies on the back of its broad product line.
Patterson Companies announces to invest in two separate businesses to boost its animal health business.
Investors remain optimistic about Patterson Companies on the back of its broad product line.
Patterson Companies (PDCO) fiscal first-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments on the back of comprehensive product offerings.
Patterson Companies (PDCO) unit and Pearl collaborate to bring advanced AI disease detection technology, Second Opinion, to Canadas dental practices, enhancing clinical performance and patient communication
Patterson Companies (PDCO) latest integration features are likely to provide customers with additional options to streamline their experience.
Patterson Companies (PDCO) fourth-quarter fiscal 2024 results reflect a year-over-year improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales improve.
Earnings call: Patterson Companies reports modest growth amid challenges
Patterson Companies (PDCO) fiscal fourth-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments.
Patterson Companies (PDCO) latest offering is likely to offer customers additional options for their electronic insurance processing and patient billing statement workflow.
Patterson Companies (PDCO) Patterson CarePay+ is likely to improve overall patient care and streamline practice operations.
Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.
Patterson Companies announces $500 million stock repurchase
Earnings call: Patterson Companies posts modest Q3 growth, revises guidance
Patterson Companies (PDCO) third-quarter fiscal 2024 results reflect an improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales appear weak.